Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nakornthon Hospital PCLBKK:NKT 16 Debt-to-EBITDA is 1.48 as of Jun. 2026, which is 573% above its 10-year median of 0.22. GuruFocus rates BKK:NKT with a GF Score™ of 16/100. The stock has 5 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Nakornthon Hospital PCL ranks better than 64.15% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Nakornthon Hospital PCL's Debt-to-EBITDA or its related term are showing as below:
BKK:NKT'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.15 Med: 0.22 Max: 1.29
Current: 1.29
During the past 4 years, the highest Debt-to-EBITDA Ratio of Nakornthon Hospital PCL was 1.29. The lowest was 0.15. And the median was 0.22.
BKK:NKT's Debt-to-EBITDA is ranked better than 64.15% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 2.18
vs BKK:NKT: 1.29
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Nakornthon Hospital PCL Debt-to-EBITDA Related Terms
Nakornthon Hospital PCL Debt-to-EBITDA Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:NKT vs HCA, THC, EHC: Debt-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Nakornthon Hospital PCL's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nakornthon Hospital PCL Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nakornthon Hospital PCL's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Nakornthon Hospital PCL's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Nakornthon Hospital PCL (BKK:NKT) has a Debt-to-EBITDA of 1.48 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Nakornthon Hospital PCL. This is 573% above median its historical median of 0.22. Over the past decade, Nakornthon Hospital PCL's Debt-to-EBITDA has ranged from 0.15 to 1.29. According to the industry distribution chart, Nakornthon Hospital PCL ranks #171 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 35.8%.
Is Nakornthon Hospital PCL's Debt-to-EBITDA too high?
Nakornthon Hospital PCL's current Debt-to-EBITDA of 1.48 is 573% above median its 10-year median of 0.22. Over the past 10 years, this metric has ranged from a low of 0.15 to a high of 1.29. The Healthcare Providers & Services industry median Debt-to-EBITDA is 2.18. Nakornthon Hospital PCL's value of 1.48 is 32.1% below this industry median. Based on the distribution chart, Nakornthon Hospital PCL ranks #171 out of 477 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nakornthon Hospital PCL has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Nakornthon Hospital PCL's Debt-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nakornthon Hospital PCL ranks #171 out of 477 companies for Debt-to-EBITDA. This puts Nakornthon Hospital PCL in the upper half of its industry. The industry median Debt-to-EBITDA is 2.18. Nakornthon Hospital PCL's value of 1.48 is 32.1% below this benchmark. Historically, Nakornthon Hospital PCL's own Debt-to-EBITDA has ranged from 0.15 to 1.29 over the past decade. While the company's 10-year median is 0.22 vs. the industry median of 2.18, Nakornthon Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.18, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nakornthon Hospital PCL's current Debt-to-EBITDA of 1.48 is 32.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Nakornthon Hospital PCL. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nakornthon Hospital PCL's current Debt-to-EBITDA is 1.48, which is 573% above median its own 10-year median of 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nakornthon Hospital PCL stock overvalued right now?
Nakornthon Hospital PCL (BKK:NKT) has a current Debt-to-EBITDA of 1.48. The current Debt-to-EBITDA is 1.48, which is 573% above median its 10-year median of 0.22 and 32.1% below the Healthcare Providers & Services industry median of 2.18. Nakornthon Hospital PCL's overall GF Score™ is 16/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Nakornthon Hospital PCL (BKK:NKT), the current Debt-to-EBITDA is 1.48 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nakornthon Hospital PCL is engaged in the healthcare industry. It is principally engaged in the hospital business offering specialty centers such as Orthopedics Center, Neurology Center, Gastrointestinal and Liver Center, and Nakornthon Fertility Center by Superior A.R.T. The company has two reportable segments which are hospital operations and other businesses that support hospital business including distribution of health and cosmetic products, facility management, and restaurant. A majority of its revenue is generated from the hospital business. Its operations are carried on in the geographical area of Thailand.
16GF Score
Get the complete analysis for BKK:NKT
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:NKT has been successfully added to your 
